Clinical Edge Journal Scan

Entheseal ultrasound by dermatologists may not be effective for screening PsA


 

Key clinical point: In patients with psoriasis, the German Psoriasis Arthritis Diagnostic (GEPARD) questionnaire followed by a dermatological assessment can detect psoriatic arthritis (PsA) risk almost accurately, and entheseal ultrasound by dermatologists shows no additional benefits in this regard.

Major finding: PsA was diagnosed in 6 out of 40 patients, with a sensitivity of 100%; however, dermatologic ultrasound evaluation of the entheses alone was unable to confirm these findings. Of the remaining 34 patients with psoriasis, 8 were deemed by dermatologists as possibly having PsA based on the ultrasound examination although rheumatologists detected ultrasound abnormalities in only 3 patients.

Study details: Findings are from a cross-sectional study including 40 patients with psoriasis who completed the GEPARD questionnaire and subsequently underwent an assessment for PsA by a dermatologist and an ultrasound examination.

Disclosures: This study was supported by a conditional research grant from Rheumazentrum Erlangen-Nuremberg e.V. and AGJR Verbundprojekt. The authors declared no conflicts of interest.

Source: Bartsch V et al. Screening for psoriatic arthritis in dermatological settings—Are handheld ultrasound devices the gamechangers we hoped for? Rheumatology (Oxford). 2023 (Nov 3). doi: 10.1093/rheumatology/kead592

Recommended Reading

Apremilast beats placebo in early PsA affecting few joints
MDedge Rheumatology
Predictors of minimal disease activity achievement in upadacitinib-treated PsA
MDedge Rheumatology
Real-world study shows favorable efficacy-safety profile of dual targeted therapy in refractory PsA
MDedge Rheumatology
Ixekizumab improves disease signs and symptoms in patients with severe PsA
MDedge Rheumatology
Tildrakizumab may check the progression to PsA in psoriatic patients
MDedge Rheumatology
Cathepsin K and G levels in serum and synovial fluid hold diagnostic potential in PsA
MDedge Rheumatology
PsA tied to increased risk of depressive symptoms and functional impairment
MDedge Rheumatology
Meta-analysis identifies the biologic and small-molecule therapies associated with infection risk in PsA
MDedge Rheumatology
Early efficacy with guselkumab predicts lower radiographic progression in PsA
MDedge Rheumatology
Syndesmophyte formation is a rare event in PsA
MDedge Rheumatology